Interview with Sergey Tjulandin

Interview with Sergey Tjulandin, MD, DSci, Professor, Deputy Director and Head of Department of Clinical Pharmacology and Chemotherapy of N.N. Blokhin Cancer Research Center (Moscow, Russia), Chair of the Russian Society of Clinical Oncology (RUSSCO), Member of RakFond’s Scientific Advisory Board.

Learn how advances in germinogenic tumors treatment let young people return to their lives, where scientific hypotheses come from and why it is important to support local clinical trials.